Search
Showing results for "Professor"
News & Events
Global push to eliminate confusion on lung function testsA global research network has taken another step towards standardising the way doctors interpret commonly used lung function tests.
News & Events
Early diagnosis for kids with autismFocussing attention on a child’s first year of life is proving to be a major breakthrough in autism research.
News & Events
New clues into language developmentA world-first study from The Kids for Child Health Research has identified risk factors for receptive language development in Australian children.
Research
Comparing and combining the effects of low dose ultraviolet and physical activityShelley Prue Gorman Hart BSc (Hons) PhD BSc (Hons) MSc PhD Honorary Research Associate Honorary Research Fellow shelley.gorman@thekids.org.au
Research
UVB phototherapy for participants with an early form of multiple sclerosisMatt Prue Stephanie Cooper Hart Trend BCA Marketing, BSc Statistics and Applied Statistics, PhD BSc (Hons) MSc PhD BSc PhD Manager, Biostatistics
News & Events
Research to explore promising new RSV treatment supported by innovation seed fundingResearchers from the Wal-yan Respiratory Research Centre are collaborating with Virex Pharma to undertake vital research into a potential breakthrough treatment for RSV infections in young children, thanks to a $499,241 grant awarded by the WA Department of Health Innovation Seed Fund.
Research
Spatiotemporal patterns of influenza in Western AustraliaUnderstanding the geospatial distribution of influenza infection and the risk factors associated with infection clustering can inform targeted preventive interventions. We conducted a geospatial analysis to investigate the spatial patterns and identify drivers of medically attended influenza infection across all age groups in Western Australia.
Research
The long-term effects of breastfeeding on child and adolescent mental health: A Pregnancy Cohort Study followed for 14 yearsTo determine whether there was an independent effect of breastfeeding on child and adolescent mental health
Research
Safety and immunogenicity of a primary series and booster dose of the meningococcal serogroup B-factor H binding protein vaccine (MenB-FHbp) in healthy children aged 1–9 years: two phase 2 randomised, controlled, observer-blinded studiesThe meningococcal serogroup B-factor H binding protein vaccine (MenB-FHbp) is licensed for use in children aged 10 years or older for protection against invasive serogroup B meningococcal disease. Because young children are at increased risk of invasive meningococcal disease, MenB-FHbp clinical data in this population are needed.
Research
Determining the pneumococcal conjugate vaccine coverage required for indirect protection against vaccine-type pneumococcal carriage in low and middle-income countriesWe will investigate the relationship between PCV coverage and VT carriage among undervaccinated children in Asia and the Pacific